Insider trading

Period: 120 months Stock: REPL Plan: Not on a plan × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

145 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

145 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

145 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

145 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
145 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
145 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

145 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
17 Aug 2026
Hill Emily Luisa Chief Financial Officer
Sold at will
$132.18K 9,256 at 14.28
4.1%
Not planned
10 Aug 2026
Patel Sushil Chief Executive Officer
Sold at will
$510.25K 39,341 at 12.97
5.3%
Not planned
10 Aug 2026
Hill Emily Luisa Chief Financial Officer
Sold at will
$148.48K 11,448 at 12.97
4.8%
Not planned
10 Aug 2026
Xynos Konstantinos Chief Medical Officer
Sold at will
$148.47K 11,447 at 12.97
4.9%
Not planned
10 Aug 2026
Schwendenman Andrew Chief Accounting Officer
Sold at will
$98.99K 7,632 at 12.97
7.1%
Not planned
18 May 2026
Patel Sushil Chief Executive Officer
Sold at will
$189.61K 37,324 at 5.08
4.8%
Not planned
18 May 2026
Sold at will
$89.70K 17,657 at 5.08
1.2%
Not planned
18 May 2026
Xynos Konstantinos Chief Medical Officer
Sold at will
$71.24K 14,023 at 5.08
5.6%
Not planned
18 May 2026
Sarchi Christopher Chief Commercial Officer
Sold at will
$43.82K 8,626 at 5.08
4.3%
Not planned
18 May 2026
Schwendenman Andrew Chief Accounting Officer
Sold at will
$40.10K 7,894 at 5.08
6.9%
Not planned
18 May 2026
Hill Emily Luisa Chief Financial Officer
Sold at will
$39.68K 7,812 at 5.08
3.2%
Not planned
9 Dec 2025
Dhingra Kapil Director
Sold at will
$32.96K 3,169 at 10.40
100%
Sold half or more
17 Nov 2025
Xynos Konstantinos Chief Medical Officer
Sold at will
$65.96K 7,248 at 9.10
4.9%
Not planned
17 Nov 2025
Sarchi Christopher Chief Commercial Officer
Sold at will
$47.39K 5,208 at 9.10
4.1%
Not planned
15 Aug 2025
Hill Emily Luisa Chief Financial Officer
Sold at will
$49.16K 9,154 at 5.37
6.4%
Not planned
20 May 2025
Sold at will
$260.17K 32,279 at 8.06
2.2%
Not planned
20 May 2025
Patel Sushil Chief Executive Officer
Sold at will
$202.35K 25,105 at 8.06
6.8%
Not planned
20 May 2025
Xynos Konstantinos Chief Medical Officer
Sold at will
$64.09K 7,952 at 8.06
5.1%
Not planned
20 May 2025
Sarchi Christopher Chief Commercial Officer
Sold at will
$30.18K 3,749 at 8.05
2.8%
Not planned
20 May 2025
Schwendenman Andrew Chief Accounting Officer
Sold at will
$26.46K 3,287 at 8.05
4.6%
Not planned
20 May 2025
Hill Emily Luisa Chief Financial Officer
Sold at will
$20.41K 2,535 at 8.05
1.7%
Not planned
18 Nov 2024
Xynos Konstantinos Chief Medical Officer
Sold at will
$78.11K 7,246 at 10.78
6.2%
Not planned
18 Nov 2024
Sarchi Christopher Chief Commercial Officer
Sold at will
$56.13K 5,207 at 10.78
5.6%
Not planned
16 Aug 2024
Hill Emily Luisa Chief Financial Officer
Sold at will
$90.99K 8,938 at 10.18
8.1%
Not planned
16 May 2024
Astley-Sparke Philip Executive Chairman
Sold at will
$245.39K 37,928 at 6.47
2.5%
Not planned
16 May 2024
Patel Sushil Chief Executive Officer
Sold at will
$130.66K 20,194 at 6.47
8.7%
Not planned
16 May 2024
Love Colin Chief Operating Officer
Sold at will
$113.97K 17,615 at 6.47
2.2%
Not planned
16 May 2024
Coffin Robert Director
Sold at will
$74.17K 11,464 at 6.47
0.6%
Not planned
16 May 2024
Xynos Konstantinos Chief Medical Officer
Sold at will
$41.19K 6,367 at 6.47
4.6%
Not planned
16 May 2024
Schwendenman Andrew Chief Accounting Officer
Sold at will
$14.87K 2,298 at 6.47
5.7%
Not planned
16 May 2024
Sarchi Christopher Chief Commercial Officer
Sold at will
$14.35K 2,218 at 6.47
2.3%
Not planned
16 Nov 2023
Xynos Konstantinos Chief Medical Officer
Sold at will
$79.86K 7,313 at 10.92
6.1%
Not planned
16 Nov 2023
Sarchi Christopher Chief Commercial Officer
Sold at will
$57.38K 5,255 at 10.92
6.8%
Not planned
16 May 2023
Astley-Sparke Philip Chief Executive Officer
Sold at will
$323.13K 17,902 at 18.05
1.2%
Not planned
16 May 2023
Patel Sushil Chief Strategy Officer
Sold at will
$281.13K 15,575 at 18.05
9.2%
Not planned
16 May 2023
Lewis Tanya Chief Dev. Op. Officer
Sold at will
$220.34K 12,207 at 18.05
7.6%
Not planned
16 May 2023
Franchi Jean M. Chief Financial Officer
Sold at will
$204.89K 11,351 at 18.05
8.1%
Not planned
16 May 2023
Love Colin Chief Operating Officer
Sold at will
$194.49K 10,775 at 18.05
1.3%
Not planned
16 May 2023
Coffin Robert President & Chief R&D Officer
Sold at will
$141.89K 7,861 at 18.05
0.4%
Not planned
16 May 2023
Esposito Pamela Chief Business Officer
Sold at will
$107.69K 5,966 at 18.05
2.2%
Not planned
16 May 2023
Xynos Konstantinos Chief Medical Officer
Sold at will
$13.92K 771 at 18.05
0.6%
Not planned
9 Dec 2022
Esposito Pamela Chief Business Officer
Sold, plan not stated
$375.45K 15,000 at 25.03
6.1%
16 May 2022
Patel Sushil Chief Commercial Officer
Sold, plan not stated
$155.92K 10,687 at 14.59
7.6%
16 May 2022
Astley-Sparke Philip Chief Executive Officer
Sold, plan not stated
$140.53K 9,632 at 14.59
0.7%
16 May 2022
Love Colin Chief Operating Officer
Sold, plan not stated
$92.27K 6,324 at 14.59
0.8%
16 May 2022
Coffin Robert President & Chief R&D Officer
Sold, plan not stated
$83.70K 5,737 at 14.59
0.3%
16 May 2022
Lewis Tanya Chief Dev. Op Officer
Sold, plan not stated
$79.85K 5,473 at 14.59
4.3%
16 May 2022
Esposito Pamela Chief Business Officer
Sold, plan not stated
$51.17K 3,507 at 14.59
1.5%
16 May 2022
Franchi Jean M. Chief Financial Officer
Sold, plan not stated
$50.13K 3,436 at 14.59
3.5%
16 Mar 2022
Sold, plan not stated 2×
$698.25K 45,000 at 15.52
1.0%
Showing 1–50 of 145. Page 1 of 3 Older →